Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial
- COMPARE ABSORB trial investigators
- Erasmus MC
- Taipei Veterans General Hospital
- Cardialysis BV
- University Hospital Erlangen
- Onze-Lieve-Vrouwziekenhuis Ziekenhuis
- Hôpital Privé Jacques Cartier
- Hospital and University Fribourg
- Jagiellonian University Medical College
- Complutense University
- Medical Center of the Johannes Gutenberg University
- Charles University in Prague
- University of Padova
- Papworth Hospital
- Hopital Privé Jacques Cartier
- University of Amsterdam
- Radboud University Nijmegen Medical Center
- Maasstad Hospital
Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
9
Citations
(Scopus)